FILING ANALYSIS · FRIDAY, OCTOBER 2
INTEGRA LIFESCIENCES HOLDINGS CORP IART — 8-K: Results of Operations and Financial Condition
neutral
Integra LifeSciences lowers full-year revenue and adjusted EPS outlook for 2026 due to the impact of flooding at its Cincinnati facility, but expects strong cash generation and progress in the broader business.
The filing
8-K - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →